6. Detailed adverse events in people with mild dementia due to Alzheimer's Disease (24‐week follow‐up, AST analysis).

Adverse event	intervention group n = 129	control group n = 129	RR and 95% CI
body as a whole	11	20	0.51 (0.23 to 1.11)
central and peripheral nervous system disorders	11	18	0.57 (0.26 to 1.27)
gastro‐intestinal system disorders	22	30	0.68 (0.37 to 1.25)
metabolic and nutritional disorders	13	9	1.49 (0.62 to 3.63)
musculo‐skeletal system disorders	10	9	1.12 (0.44 to 2.86)
psychiatric disorders	15	16	0.93 (0.44 to 1.97)
respiratory system disorders	10	15	0.64 (0.28 to 1.48)
skin and appendages disorders	4	10	0.38 (0.12 to 1.25)
other (e.g. falls to surgical intervention)	8	8	1.00 (0.36 to 2.75)